SVCM
Saturn V Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.59M | Sell |
38,191
-161,073
| -81% | -$27.8M | 2.67% | 16 |
|
|
2025
Q1 | $31.1M | Buy |
199,264
+287
| +0.1% | +$44.7K | 15.67% | 1 |
|
|
2024
Q4 | $27.4M | Sell |
198,977
-1,308
| -0.7% | -$180K | 10.73% | 2 |
|
|
2024
Q3 | $29.9M | Buy |
200,285
+87,061
| +77% | +$13M | 10.69% | 1 |
|
|
2024
Q2 | $15.4M | Buy |
113,224
+9,796
| +9% | +$1.34M | 5.83% | 5 |
|
|
2024
Q1 | $15.6M | Sell |
103,428
-28,331
| -22% | -$4.28M | 6.27% | 7 |
|
|
2023
Q4 | $16.6M | Buy |
131,759
+19,286
| +17% | +$2.43M | 6.35% | 6 |
|
|
2023
Q3 | $10.5M | Buy |
112,473
+34,031
| +43% | +$3.19M | 4.41% | 12 |
|
|
2023
Q2 | $7M | Buy |
78,442
+1,232
| +2% | +$110K | 3.88% | 13 |
|
|
2023
Q1 | $8.28M | Buy |
77,210
+8,806
| +13% | +$944K | 6.18% | 10 |
|
|
2022
Q4 | $7.95M | Buy |
+68,404
| New | +$7.95M | 6.6% | 6 |
|